4CPS-006 Adherence to nebulised antibiotics in cystic fibrosis patients after starting elexacaftor/tezacaftor/ivacaftor

Background and ImportanceElexacaftor/tezacaftor/ivacaftor (ETI) are bringing about a major change in the treatment of cystic fibrosis (CF) patients. However, continuing with other treatments such as nebulised antibiotics is necessary.Aim and ObjectivesTo assess the adherence to inhaled antibiotics b...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of hospital pharmacy. Science and practice 2024-03, Vol.31 (Suppl 1), p.A53-A54
Hauptverfasser:	Martínez de la Torre, F, Diab Caceres, L, Bertran De Lis Bartolome, B, Gonzalez sevilla, M, Canales Siguero, MD, Jimenez Leon, MDC, Mayo Olveira, F, Castro Frontiñan, A, Gonzalez Gomez, A, Ferrari Piquero, JM
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibiotics Conflicts of interest Cystic fibrosis Section 4: Clinical pharmacy services
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!